Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maura L Gillison

Showing results (91-100 of 153) with videos related to

Pageof 16
Sort By:
BMC Infectious Diseases|November 27, 2015
Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methodsFelipe A Castro, Jill Koshiol, Wim Quint, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2015
Defects in the Fanconi Anemia Pathway in Head and Neck Cancer Cells Stimulate Tumor Cell Invasion through DNA-PK and Rac1 SignalingLindsey E Romick-Rosendale, Elizabeth E Hoskins, Lisa M Privette Vinnedge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2019
Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab UseRobert L Ferris, Lisa Licitra, Jerome Fayette, et al.
Cytokine|April 12, 2016
Association of serum cytokines with oral HPV clearanceJennifer O Lam, Jay H Bream, Elizabeth A Sugar, et al.
Head & Neck|November 3, 2021
Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522Elaine O Bigelow, Jonathan Harris, Carole Fakhry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research GroupShanthi Marur, Shuli Li, Anthony J Cmelak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Human papillomavirus and rising oropharyngeal cancer incidence in the United StatesAnil K Chaturvedi, Eric A Engels, Ruth M Pfeiffer, et al.
JAMA Network Open|May 5, 2025
Oral Microbiome Profile of the US PopulationAnil K Chaturvedi, Emily Vogtmann, Jianxin Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2014
Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicityPhuc Felix Nguyen-Tan, Qiang Zhang, K Kian Ang, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
The oral microbiome and all-cause mortality in the US populationEmily Vogtmann, Yukiko Yano, Jianxin Shi, et al.
Pageof 16

Showing results (91-100 of 153) with videos related to

Sort By:
Pageof 16
BMC Infectious Diseases|November 27, 2015
Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methodsFelipe A Castro, Jill Koshiol, Wim Quint, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2015
Defects in the Fanconi Anemia Pathway in Head and Neck Cancer Cells Stimulate Tumor Cell Invasion through DNA-PK and Rac1 SignalingLindsey E Romick-Rosendale, Elizabeth E Hoskins, Lisa M Privette Vinnedge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2019
Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab UseRobert L Ferris, Lisa Licitra, Jerome Fayette, et al.
Cytokine|April 12, 2016
Association of serum cytokines with oral HPV clearanceJennifer O Lam, Jay H Bream, Elizabeth A Sugar, et al.
Head & Neck|November 3, 2021
Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522Elaine O Bigelow, Jonathan Harris, Carole Fakhry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research GroupShanthi Marur, Shuli Li, Anthony J Cmelak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Human papillomavirus and rising oropharyngeal cancer incidence in the United StatesAnil K Chaturvedi, Eric A Engels, Ruth M Pfeiffer, et al.
JAMA Network Open|May 5, 2025
Oral Microbiome Profile of the US PopulationAnil K Chaturvedi, Emily Vogtmann, Jianxin Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2014
Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicityPhuc Felix Nguyen-Tan, Qiang Zhang, K Kian Ang, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
The oral microbiome and all-cause mortality in the US populationEmily Vogtmann, Yukiko Yano, Jianxin Shi, et al.
Pageof 16